Janssen Submits Two Applications To FDA Seeking Approval Of Simponi Aria ® (Golimumab) For The Treatment Of Active Psoriatic Arthritis And Active Ankylosing Spondylitis
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Ankylosing Spondylitis | Arthritis | Pharmaceuticals | Psoriatic Arthritis | Rheumatology